Abstract
Purpose: The study purpose was to pilot test a web-based human papillomavirus (HPV) vaccination intervention among young gay and bisexual men (YGBM). Methods: In 2016, we recruited 150 unvaccinated YGBM aged 18-25 years from the United States. We randomized participants to the Outsmart HPV intervention or a control group. Results: HPV vaccine initiation was higher among the intervention group than the control group (45% vs. 26%; odds ratio [OR] = 2.34, 95% confidence interval [CI]: 1.18-4.67). We observed a trend toward higher HPV vaccine completion among the intervention group (11% vs. 3%; OR = 4.24, 95% CI: 0.87-20.66). Conclusions: Outsmart HPV is a promising strategy for increasing HPV vaccination among YGBM.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 325-329 |
| Number of pages | 5 |
| Journal | LGBT Health |
| Volume | 5 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jul 2018 |
Bibliographical note
Funding Information:This study was supported by the National Cancer Institute of the National Institutes of Health under Award Number R21CA194831. This clinical trial is registered at Clinical-Trials.gov: identifier NCT02835755. We thank the Center for Health Communications Research at the University of Michigan for their contributions during the development and implementation of this intervention.
Funding Information:
P.L.R. has received research grants from Merck Sharp & Dohme Corp. and Cervical Cancer-Free America, through an unrestricted educational grant from GlaxoSmithKline. E.D.P. has received research grants from Merck Sharp & Dohme Corp. These funds were not used to support this research study. None of the other authors have disclosures to report.
Publisher Copyright:
© Copyright 2018, Mary Ann Liebert, Inc.
Keywords
- HPV
- HPV vaccine
- intervention
- sexual minority men